THE INTERACTION BETWEEN EXERCISE AND MEDICATIONS ON BLOOD GLUCOSE RESPONSE IN TYPE 2 DIABETIC SUBJECTS

Type 2 diabetes is increasing rapidly worldwide and the rate of growth is particularly pronounced in developing countries. It is estimated that in the world, in the year 2030 there will be approximately 439 million people with diabetes, compared with 285 million who were estimated in 2010. Two hundreds eighty one subjects (169 M and 112 F) with Type 2 Diabetes were recruited according to well defined exclusion/inclusion criteria and informed about the study. All subjects executed a supervised training program consisting in mixed (aerobic and resistance) exercise sessions, according to the most recent ACSM-ADA guidelines and after being tested to determine the correct training intensities on both aerobic and strength exercises. As previously confirmed in the literature, covariates significantly related to blood glucose reduction were age, numer of sessions, exercise duration and pre-exercise blood glucose levels. Differently from what was hypotized, it has been found that prandial time was not a significant covariate.